Physician profile
Ignacio Chiong
NPI 1629292255
$8,943.02
in general payments reported to CMS, 2019-2025
7 companies · $4,307 in 2025
The $4,307 reported for 2025 was more than what 84% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.79 · 2021: $627 · 2022: $31.19 · 2023: $57.46 · 2024: $3,901 · 2025: $4,307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,095 · Food and Beverage: $2,920 · Consulting Fee: $2,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,095.11 |
| Food and Beverage | $2,919.83 |
| Consulting Fee | $2,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,038.85 | 2022-2025 | Obsidio, Therasphere Y90 Glass Microspheres 10 Gbq, General - Therapies |
| Inari Medical, INC. | $517.11 | 2021 | |
| Medtronic, INC. | $152.25 | 2021-2024 | Concertotm |
| Stryker Corporation | $123.03 | 2025 | Clottriever Bold Catheter, Flowtriever |
| Bard Peripheral Vascular, INC. | $51.27 | 2019-2025 | Pleurx |
| Cordis US Corp. | $37.08 | 2022-2023 | Brite Tip Radianz |
| Angiodynamics, INC. | $23.43 | 2025 | Alphavac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ignacio Chiong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.